on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Files Disclosure for Spire Healthcare
The Vanguard Group, Inc. has filed a Form 8.3 related to its interests in Spire Healthcare Group plc. As of May 19, 2026, Vanguard holds 14,430,290 ordinary shares, translating to a 3.58% interest in Spire Healthcare. The disclosure complies with Rule 8.3 of the Takeover Code, highlighting positions in relevant securities accounting for 1% or more.
The filing details transactions in ordinary shares, including the purchase of 2,508 shares at 2.19 GBP each and sales totaling 10,922 shares at prices between 2.18 and 2.19 GBP. Moreover, no cash-settled derivatives or new securities rights were identified in this disclosure, highlighting a straightforward equity interest.
No indemnity or other dealing arrangements have been reported, nor are there agreements regarding voting rights or derivative-related securities. This transparency ensures compliance with regulatory requirements.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news